Baker, Donelson, Bearman, Caldwell & Berkowitz has added three patent lawyers in Washington from three different law firms.
David Woodward, who joins as a shareholder, comes from Sidley Austin. He represents pharmaceutical, chemical and biotechnology companies from procurement to litigation. He also performs intellectual property audits.
Thor Nielsen, who joins as a patent attorney, comes from Connolly Bove Lodge & Hutz. He focuses on drafting and prosecuting patent applications in the pharmaceutical, chemical, agroscience, metallurgy and drug delivery fields.
Ryan Brady, who joins as an associate, comes from Oliff & Berridge in Alexandria, Va. He focuses on patent prosecution and litigation, with a primary emphasis on biotechnology and chemical matters.
"Their backgrounds and knowledge are strong complements to the broad spectrum of capabilities already offered by our Life Sciences team," said John Calender, managing shareholder of the Washington office, in a statement.
Updated 6:30 p.m.
John Calender, managing shareholder of the Washington office of Baker Donelson, said the hiring of Woodward, Nielsen and Brady reflects the growing importance of biotech, pharmaceutical and chemical companies in the U.S. economy. “It’s an area that’s becoming increasingly important with respect to health care issues,” he said.
Susan McBee, head of the life sciences division of the firm’s IP practice, expects the number of patent applications and disputes to rise in the near future. “With the economy turning around, more people are putting money into their patent portfolio,” she said.